Lifestyle Risk Factors, Cardiometabolic Diseases Prevalent in Young Adults
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 24, 2023 -- U.S. young adults have a high prevalence of lifestyle risk factors and cardiometabolic diseases, with varying rates based on race and ethnicity, according to a study published online Aug. 23 in the Journal of the American Heart Association.
Shuxiao Shi, from Shanghai Jiao Tong University School of Medicine, and colleagues examined the prevalence of lifestyle risk factors and cardiometabolic diseases among adults aged 18 to 44 years from the National Health and Nutrition Examination Survey, 2011 to 2018. The age-standardized prevalence of lifestyle risk factors and cardiometabolic diseases was estimated overall and by demographic and social risk factors.
Data were included for 10,405 participants (median age, 30.3 years). The researchers found that the prevalence of lifestyle factors varied from 16.3 to 49.3 percent for excessive drinking and poor diet quality, respectively. Cardiometabolic disease prevalence varied from 4.3 percent for diabetes to 37.3 percent for dyslipidemia. The prevalence of having two or more lifestyle risk factors and two or more cardiometabolic diseases was 45.2 and 22.0 percent, respectively. After adjustment for social risk factors and lifestyle factors, racial and ethnic disparities in many cardiometabolic diseases persisted but were attenuated.
"Given that cardiometabolic diseases are largely preventable and lifestyle behaviors are theoretically modifiable, devising effective and targeted interventions to improve cardiometabolic health in young adults would deliver long-term health benefits," coauthor Nannan Feng, Ph.D., also of Shanghai Jiao Tong University School of Medicine, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.